N,N'-Dipropyl-piperazin | 25115-78-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: N,N'-Dipropyl-piperazin
• 英文别名: 1,4-dipropyl-piperazine；1,4-Dipropyl-piperazin；N,N'-dipropylpiperazine；1,4-Dipropylpiperazine
• CAS: 25115-78-0
• 化学式: C₁₀H₂₂N₂
• 分子量: 170.298
• InChiKey: IVMKBBDVVDYGPS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  6.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N,N'-Dipropyl-piperazin 以79%的产率得到
  参考文献：
  名称：

  DEVINSKY, F.;LACKO, I.;MLYNARCIK, D.;KRASNEC, L., COLLECT. CZECH. CHEM. COMMUN., 1982, 47, N 4, 1130-1138

  摘要：

  DOI：
• 作为产物：
  描述：

  1,1,4,4-tetrapropyl-piperazinediium; dichloride 生成 N,N'-Dipropyl-piperazin
  参考文献：
  名称：

  Cadogan, Journal of the Chemical Society, 1955, p. 2971

  摘要：

  DOI：

文献信息

• Alkyl Group VA metal compounds
  申请人：Shipley Company, L.L.C.

  公开号：US20030181746A1

  公开（公告）日：2003-09-25

  Disclosed are methods of preparing monoalkyl Group VA metal dihalide compounds in high yield and high purity by the reaction of a Group VA metal trihalide with an organo lithium reagent or a compound of the formula R n M 1 X 3−n , where R is an alkyl, M 1 is a Group IIIA metal, X is a halogen and n is an integer fro 1 to 3. Such monoalkyl Group VA metal dihalide compounds are substantially free of oxygenated impurities, ethereal solvents and metallic impurities. Monoalkyl Group VA metal dihydride compounds can be easily produced in high yield and high purity by reducing such monoalkyl Group VA metal dihalide compounds.

  揭示了通过将VA族金属三卤化物与有机锂试剂或具有公式RnM1X3−n的化合物（其中R是烷基，M1是III A族金属，X是卤素，n是1到3的整数）反应，以高产率和高纯度制备单烷基VA族金属二卤化合物的方法。这种单烷基VA族金属二卤化合物基本上不含氧杂质、醚溶剂和金属杂质。通过还原这种单烷基VA族金属二卤化合物，可以轻松地高产率和高纯度地生产单烷基VA族金属二氢化合物。
• FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS
  申请人：BONO Francoise

  公开号：US20090069368A1

  公开（公告）日：2009-03-12

  FGF receptor agonist compounds corresponding to the general formula: M1-L-M2 are disclosed in which M1 and M2, which may be identical or different, each represent, independently of one another, a monomer unit M, and L represents a linker group, wherein the monomer unit is of the general formula I.

  公开了对应于一般公式 M1-L-M2 的FGF受体激动剂化合物，其中M1和M2相同或不同，每个独立地表示一个单体单元M，L表示连接基团，其中单体单元是通用公式I。
• [EN] SELECTIVE MODULATORS OF MUTANT LRRK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE<br/>[FR] MODULATEURS SÉLECTIFS DE LA PROTÉOLYSE DE LA LRRK2 MUTANTE ET MÉTHODES D'UTILISATION ASSOCIÉES
  申请人：ARVINAS OPERATIONS INC

  公开号：WO2021194878A1

  公开（公告）日：2021-09-30

  Bifunctional compounds, which find utility as modulators of non-receptor Leucine-rich repeat kinase 2 (LRRK2), are described herein. In particular, the bifunctional compounds of the present disclosure contain on one end a moiety that binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds LRRK2, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本文描述了作为非受体白氨酸富含重复激酶2（LRRK2）调节剂的双功能化合物。具体来说，本公开的双功能化合物在一端含有结合到 cereblon E3 泛素连接酶的基团，在另一端含有结合到 LRRK2 的基团，使得目标蛋白质靠近泛素连接酶以实现目标蛋白质的降解（和抑制）。本公开的双功能化合物表现出与目标蛋白质的降解/抑制相关的广泛药理活性。由于目标蛋白质异常调节导致的疾病或紊乱可通过本公开的化合物和组合物进行治疗或预防。
• [EN] HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION<br/>[FR] DÉGRONIMÈRES HÉTÉROCYCLIQUES POUR LA DÉGRADATION DE PROTÉINES CIBLES
  申请人：C4 THERAPEUTICS INC

  公开号：WO2017197055A1

  公开（公告）日：2017-11-16

  This invention provides heterocyclic compounds that bind to E3 Ubiquitin Ligase (typically through cereblon) ("Degrons"), which can be used as is or linked to a Targeting Ligand for a selected Target Protein for therapeutic purposes and methods of use and compositions thereof as well as methods for their preparation.

  这项发明提供了结合到E3泛素连接酶（通常通过cereblon）的杂环化合物（“Degrons”），可以直接使用，也可以与靶向配体连接到选择的靶蛋白上，用于治疗目的，以及它们的使用方法、组合物以及制备方法。
• Process for Isomerization of CIS-2-Pentenenitrile to 3-Pentenenitriles
  申请人：BASF SE

  公开号：US20130289299A1

  公开（公告）日：2013-10-31

  The present invention relates to an improved process for batchwise or continuous isomerization of cis-2-pentenenitrile to 3-pentenenitriles in the presence of 1,4-diazabicyclo[2.2.2]octane as catalyst.

  本发明涉及在1,4-二氮杂双环[2.2.2]辛烷存在下，对顺-2-戊烯腈进行批量或连续异构化改进过程，以得到3-戊烯腈。